-
Dermaliq Therapeutics Announces Positive Topline Results from Phase 1b/2a Trial Evaluating the Safety and Efficacy of DLQ01 for the Treatment of Androgenetic Alopecia (AGA) in Men
Biotech Newswire
July 17, 2024
DLQ01 is potentially the first new topical treatment option for both men and women suffering from AGA in a very long time.
-
Dermatology biotech Dermata Therapeutics sets terms for $15 million IPO
firstwordpharma
July 05, 2021
Dermata Therapeutics plans to raise $15 million in its initial public offering of 1.9 million shares at a price range of $7 to $9, Renaissance Capital reported.
-
Organon launches as Women’s Health company
expresspharma
June 04, 2021
Organon is a new company focused on women’s health. In India, Organon will be operating in women’s healthcare, fertility, dermatology, respiratory and bone health products in their portfolio.
-
Lincoln Pharmaceuticals receives EU GMP approval
expresspharma
May 20, 2020
The company looks to enter the EU markets very soon with its dermatology, gastro and pain management products and gradually expand product portfolio.
-
Galderma Launches Online Support to Empower and Equip Rosacea Sufferers to Discuss the True Burden of Their Disease With a Dermatologist
En-CPhI.CN
October 23, 2019
Launched Galderma's new Face up to rosacea campaign aims to help close the communication gap between people with rosacea and dermatologists.
-
LEO Pharma completes the acquisition of Bayer’s prescription dermatology business
worldpharmanews
July 03, 2019
LEO Pharma completes the acquisition of Bayer’s prescription dermatology business.
-
FDA dermatology advisors found to accept payments after drug approvals
europeanpharmaceuticalreview
June 14, 2019
A study has shown that the majority of dermatology advisors to the FDA took payments subsequent to drug approvals.
-
Glenmark forays into branded dermatology segment in US
expressbpd
December 20, 2018
The branded portfolio for the US market will be developed and commercialised by Glenmark Therapeutics USA
-
LEO Pharma teams up with Wearifi for dermatology research wearable
pharmaphorum
December 19, 2018
LEO Pharma is developing a wearable device based on miniature sensors and plans to assess its clinical potential in dermatology drug development.
-
Almirall and X-Chem Announce Dermatology-Focused Drug Discovery Collaboration
pharmafocusasia
December 13, 2018
X-Chem, Inc., a privately held biotechnology company applying its innovative drug discovery platform to the generation of novel small molecule therapeutics....